Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 8,367,687	$ 13,070,108	$ 15,064,000	$ 15,306,451
General and administrative	1,233,040	573,360	2,044,332	1,128,787
Total operating expenses	9,600,727	13,643,468	17,108,332	16,435,238
Loss from operations	(9,600,727)	(13,643,468)	(17,108,332)	(16,435,238)
Other income (expense)
Interest expense	(455,445)	(391,187)	(890,446)	(391,210)
Interest income	95,646	1,803	103,805	2,191
Loss on sale of fixed assets				(263)
Other income (expense), net	(359,799)	(389,384)	(786,641)	(389,282)
Net loss before income taxes	(9,960,526)	(14,032,852)	(17,894,973)	(16,824,520)
Income tax benefits
Net loss	$ (9,960,526)	$ (14,032,852)	$ (17,894,973)	$ (16,824,520)
Net loss per share, basic and diluted	$ (0.67)	$ (1.11)	$ (1.20)	$ (1.42)
Weighted average common shares outstanding, basic and diluted	14,930,538	12,610,917	14,923,900	11,845,758